These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 17846116)
1. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116 [TBL] [Abstract][Full Text] [Related]
2. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Gubbels MJ; Striepen B; Shastri N; Turkoz M; Robey EA Infect Immun; 2005 Feb; 73(2):703-11. PubMed ID: 15664908 [TBL] [Abstract][Full Text] [Related]
4. The involvement of immunoproteasomes in induction of MHC class I-restricted immunity targeting Toxoplasma SAG1. Ishii K; Hisaeda H; Duan X; Imai T; Sakai T; Fehling HJ; Murata S; Chiba T; Tanaka K; Hamano S; Sano M; Yano A; Himeno K Microbes Infect; 2006 Apr; 8(4):1045-53. PubMed ID: 16515877 [TBL] [Abstract][Full Text] [Related]
5. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection. Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549 [TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells. Yano A; Aosai F; Ohta M; Hasekura H; Sugane K; Hayashi S J Parasitol; 1989 Jun; 75(3):411-6. PubMed ID: 2786064 [TBL] [Abstract][Full Text] [Related]
7. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. Bertholet S; Goldszmid R; Morrot A; Debrabant A; Afrin F; Collazo-Custodio C; Houde M; Desjardins M; Sher A; Sacks D J Immunol; 2006 Sep; 177(6):3525-33. PubMed ID: 16951311 [TBL] [Abstract][Full Text] [Related]
8. Rhoptry and Dense Granule Secreted Effectors Regulate CD8 Rommereim LM; Fox BA; Butler KL; Cantillana V; Taylor GA; Bzik DJ Front Immunol; 2019; 10():2104. PubMed ID: 31555296 [No Abstract] [Full Text] [Related]
15. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. Martinez-Kinader B; Lipford GB; Wagner H; Heeg K Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131 [TBL] [Abstract][Full Text] [Related]
16. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194 [TBL] [Abstract][Full Text] [Related]
17. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163 [TBL] [Abstract][Full Text] [Related]
18. Transnuclear CD8 T cells specific for the immunodominant epitope Gra6 lower acute-phase Toxoplasma gondii burden. Sanecka A; Yoshida N; Dougan SK; Jackson J; Shastri N; Ploegh H; Blanchard N; Frickel EM Immunology; 2016 Nov; 149(3):270-279. PubMed ID: 27377596 [TBL] [Abstract][Full Text] [Related]
19. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection. Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126 [TBL] [Abstract][Full Text] [Related]
20. Development of a system to study CD4+-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Pepper M; Dzierszinski F; Crawford A; Hunter CA; Roos D Infect Immun; 2004 Dec; 72(12):7240-6. PubMed ID: 15557649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]